SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001104659-23-110172
Filing Date
2023-10-19
Accepted
2023-10-19 17:23:44
Documents
14
Period of Report
2023-09-29
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A tm2328500d1_8ka.htm   iXBRL 8-K/A 32496
2 EXHIBIT 99.3 tm2328500d1_ex99-3.htm EX-99.3 313499
  Complete submission text file 0001104659-23-110172.txt   604606

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA gfor-20230929.xsd EX-101.SCH 3272
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gfor-20230929_def.xml EX-101.DEF 26915
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE gfor-20230929_lab.xml EX-101.LAB 36508
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gfor-20230929_pre.xml EX-101.PRE 25539
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2328500d1_8ka_htm.xml XML 5679
Mailing Address 3001 DAIMLER ST, SANTA ANA CA 92705
Business Address 3001 DAIMLER ST, SANTA ANA CA 92705 (949) 396-6830
NKGen Biotech, Inc. (Filer) CIK: 0001845459 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-40427 | Film No.: 231335489
SIC: 2836 Biological Products, (No Diagnostic Substances)